An AI-integrated patient-derived organoid platform to enable high-throughput drug response prediction in glioma. PTPRZ1–MET fusion and induction of reprogrammed immuno-microenvironment via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results